Mountain View, CANCT06769048Now EnrollingIRB Ready

Macular Degeneration Clinical Trial in Mountain View, CA

Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Mountain View. Study-provided care at no cost to qualified participants.

Sponsored by Boehringer Ingelheim

Quick Self-Assessment

See if you qualify for this Mountain View location

Preparing your pre-screening questions...

Expert Care in Mountain View

Access macular degeneration specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related macular degeneration treatment provided free

Apply for This Mountain View Location

Check if you qualify for this macular degeneration clinical trial in Mountain View, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Mountain View

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Mountain View site if eligible
  4. 4Begin participation

About This Macular Degeneration Study in Mountain View

This study is open to adults aged 50 years and older with geographic atrophy that was diagnosed by imaging of the retina. The purpose of this study is to find out whether a medicine called BI 1584862 improves the eyes in people with geographic atrophy and to find the most suitable dose. This study has 4 treatment groups. Participants are put into groups randomly, which means by chance. Initially participants can join a BI 1584862 and a placebo group; then more participants are put randomly in 2

Sponsor: Boehringer Ingelheim

Who Can Participate

Inclusion Criteria

Men and women with at least 1 eye with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) determined by fundus autofluorescence (FAF). The total size of all GA lesions in the study eye (as determined by the independent central reading center (CRC)) must be ≥1.25 mm\^2 and ≤12.0 mm\^2:
If multiple lesions are present in the study eye, at least 1 lesion must have an area of ≥0.5 mm\^2
At least 1 GA lesion must be at least in part within a 1500 μm radius ring centered on the fovea
The foveal center point must not be involved in any atrophic lesion
Lesion(s) must reside completely within the FAF image
Best corrected visual acuity (BCVA) score of ≥50 letters in the study eye using the early treatment diabetic retinopathy study (ETDRS) chart (approximately equivalent to ≥20/100 on the Snellen chart).
Hyperautofluorescence of any pattern, as assessed by the CRC, must be present in the junctional zone of GA in the study eye.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Mountain View?

Yes, this clinical trial (NCT06769048) has an active research site in Mountain View, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Macular Degeneration Treatment Options in Mountain View, CA

If you're searching for macular degeneration treatment options in Mountain View, CA, this clinical trial (NCT06769048) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Mountain View research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all macular degeneration clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Mountain View, CA

See all rheumatoid arthritis clinical trials recruiting in Mountain View — not just this study.

Browse Rheumatoid Arthritis Trials in Mountain View →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsMacular Degeneration TrialsWet Age-Related Macular Degeneration TrialsAll Conditions →

Ready to Join in Mountain View?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Mountain View, CA